Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR CARISMA Therapeutics Inc (W2J.SG) Follow Add holdings 0.1633 -0.0056 (-3.32%) As of 8:02:42 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for W2J.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: W2J.SG View More All News Press Releases SEC Filings Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations Carisma Therapeutics Provides Corporate Updates Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 Carisma Therapeutics Announces Changes to its Board of Directors Related Tickers GTBP GT Biopharma, Inc. 2.4500 +1.24% IMNN Imunon, Inc. 0.8400 0.00% VTGN Vistagen Therapeutics, Inc. 2.3600 +0.85% NWBO Northwest Biotherapeutics, Inc. 0.3000 -0.33%